2023 In Review

2023 In Review

At Pfizer, we are working tirelessly to outdo yesterday by bringing new breakthroughs to patients around the globe in innovative ways. As we do this, it's important that we take the time to reflect on both our challenges and our achievements. Every March, we share those reflections in our Annual Review and Impact Report.

Pfizer Impact: Responsible Business

Pfizer Impact: Responsible Business

We're committed to creating a better tomorrow for the planet and humanity. Our 2023 Pfizer Impact Report highlights our Environmental, Social, and Governance goals and the progress we've made toward building a more sustainable future.

Pfizer Named One of the World's Most Ethical Companies

Pfizer Named One of the World's Most Ethical Companies

At Pfizer, we believe that doing the right thing is not just good for business - it's essential to building trust. We're proud to have again been named one of Ethisphere's World's Most Ethical companies, reaffirming our unwavering commitment to integrity and quality.

Pfizer Celebrates Legacy, Justice, and Equity

Pfizer Celebrates Legacy, Justice, and Equity

Pfizer colleagues reflected on the significance of the Martin Luther King, Jr holiday and Black History Month with a series of events organized by members of Pfizer's Global Black Community (GBC).

What To Know About Adcetris - Pfizer's Cancer Drug

What To Know About Adcetris - Pfizer's Cancer Drug

Patients with diffuse large B-cell lymphoma showed a "statistically significant and clinically meaningful improvement" in overall survival-the amount of time a patient lives after receiving a diagnosis-after they were treated with Adcetris in combination with two other drugs, Pfizer said.